A wave of cancellations and delays in green hydrogen projects in northern Europe is shifting focus towards the development of Iberian facilities and the construction of the H2Med pipeline. Enagas CEO, Arturo Gonzalo, emphasized the strategic importance of the H2Med project, aiming to connect green hydrogen production in Iberia with industrial buyers in central Europe, aligning with EU's ambitious green hydrogen targets. Despite setbacks in the green hydrogen sector in Spain and Europe, Enagas remains optimistic about the future, leveraging support from France, Portugal, Spain, and Germany for the H2Med project. The company's decision to divest its US division and concentrate on hydrogen investments in Spain demonstrates a commitment to the growing green energy sector. While facing financial losses, Enagas anticipates a competitive green hydrogen market by 2030, driven by a reduction in inflation and expected rise in carbon prices. Gonzalo views the recent challenges in green hydrogen projects as temporary, emphasizing the continued pursuit of 2030 goals without questioning the broader green hydrogen targets set by Europe. The adjustments in the industry are seen as part of the deployment of a new energy vector, requiring adaptation and regulatory support.